Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans

13Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Candida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive candidiasis. In this study, we report the antimorphogenetic properties of thirty cancer drugs. © 2013, Sociedade Brasileira de Microbiologia.

Cite

CITATION STYLE

APA

Routh, M. M., Chauhan, N. M., & Karuppayil, S. M. (2013). Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans. Brazilian Journal of Microbiology, 44(3), 855–859. https://doi.org/10.1590/S1517-83822013000300029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free